800 Nicollet Mall | ||
Minneapolis, Minnesota | 55402 | |
(Address of principal executive offices) | (Zip Code) |
Delaware | 23-3079390 | |
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
1300 Morris Drive | ||
Chesterbrook, Pennsylvania | 19087 | |
(Address of Principal Executive Offices) | (Zip Code) |
I.R.S. | ||||
Employer | ||||
Jurisdiction of | Identification | |||
Exact Name of Additional Obligors * | Incorporation | Number | ||
Ambulatory Pharmaceutical Services, Inc. |
New Jersey | 22-3125982 | ||
AmerisourceBergen Drug Corporation |
Delaware | 23-2353106 | ||
AmerisourceBergen Holding Corporation |
Delaware | 33-1123049 | ||
AmerisourceBergen Services Corporation |
Delaware | 23-2546940 | ||
AmerisourceBergen Specialty Group, Inc. |
Delaware | 26-4394862 | ||
AmeriSource Health Services Corporation |
Delaware | 52-1489606 | ||
AmeriSource Heritage Corporation |
Delaware | 51-0382309 | ||
Anderson Packaging, Inc. |
Illinois | 36-2653297 | ||
APS Enterprises Holding Company, Inc. |
Delaware | 23-3016067 | ||
ASD Specialty Healthcare, Inc. |
California | 33-0800482 | ||
AutoMed Technologies, Inc. |
Delaware | 36-3932047 | ||
Bellco Drug Corp. |
New York | 11-1963334 | ||
Clinical Outcomes Resource Application
Corporation |
New York | 20-3391360 | ||
Dialysis Purchasing Alliance, Inc. |
New York | 11-3381756 | ||
Health Services Capital Corporation |
Delaware | 51-0294301 | ||
I.g.G. of America, Inc. |
Maryland | 52-2062730 | ||
IHS Acquisition XXX, Inc. |
Delaware | 52-2060810 | ||
Imedex, LLC |
Georgia | 02-0601048 | ||
Integrated Commercialization Solutions, Inc. |
California | 75-2758166 | ||
International Physician Networks, L.L.C. |
Delaware | 52-2207795 | ||
Liberty Acquisition Corp. |
Delaware | 20-8743926 | ||
Medical Initiatives, Inc. |
Florida | 59-3550338 | ||
Pharm Plus Acquisition, Inc. |
Delaware | 06-1640259 | ||
Pharmacy Healthcare Solutions, Ltd. |
Texas | 75-2661419 | ||
Solana Beach, Inc. |
Delaware | 59-3762480 | ||
Specialty Pharmacy, Inc. |
Delaware | 23-3003463 | ||
Specialty Pharmacy of California, Inc. |
California | 23-3041534 | ||
Telepharmacy Solutions, Inc. |
Delaware | 04-3252233 | ||
The Lash Group, Inc. |
Delaware | 52-1663991 | ||
US Bioservices Corporation |
Delaware | 04-3734758 | ||
Value Apothecaries, Inc. |
Texas | 75-2660314 | ||
Xcenda, LLC |
Florida | 04-3697141 |
* | The address of principal executive office for each additional obligor above is c/o AmerisourceBergen Corporation, 1300 Morris Drive, Chesterbrook, Pennsylvania 19087. |
2
Item 1. | GENERAL INFORMATION. Furnish the following information as to the Trustee. |
a) | Name and address of each examining or supervising authority to which it is subject. |
b) | Whether it is authorized to exercise corporate trust powers. |
Item 2. | AFFILIATIONS WITH OBLIGOR. If the obligor is an affiliate of the Trustee, describe each such affiliation. |
Items 3-15 | Items 3-15 are not applicable because to the best of the Trustees knowledge, the obligor is not in default under any Indenture for which the Trustee acts as Trustee. |
Item 16. | LIST OF EXHIBITS: List below all exhibits filed as a part of this statement of eligibility and qualification. |
1. | A copy of the Articles of Association of the Trustee.* | ||
2. | A copy of the certificate of authority of the Trustee to commence business.* | ||
3. | A copy of the certificate of authority of the Trustee to exercise corporate trust powers.* | ||
4. | A copy of the existing bylaws of the Trustee.** | ||
5. | A copy of each Indenture referred to in Item 4. Not applicable. | ||
6. | The consent of the Trustee required by Section 321(b) of the Trust Indenture Act of 1939, attached as Exhibit 6. | ||
7. | Report of Condition of the Trustee as of June 30, 2009 published pursuant to law or the requirements of its supervising or examining authority, attached as Exhibit 7. |
* | Incorporated by reference to Exhibit 25.1 to Amendment No. 2 to registration statement on
S-4, Registration Number 333-128217 filed on November 15, 2005. |
|
** | Incorporated by reference to Exhibit 25.1 to registration statement on S-4, Registration Number 333-145601 filed on August 21, 2007. |
3
By: | /s/ George J. Rayzis | |||
George J. Rayzis | ||||
Vice President | ||||
By:
|
/s/ Ralph E. Jones
|
|||
Vice President |
4
By: | /s/ George J. Rayzis | |||
George J. Rayzis | ||||
Vice President | ||||
By:
|
/s/ Ralph E. Jones
|
|||
Vice President |
5
6/30/2009 | ||||
Assets |
||||
Cash and Balances Due From
Depository Institutions |
$ | 6,526,915 | ||
Securities |
38,971,863 | |||
Federal Funds |
3,558,381 | |||
Loans & Lease Financing Receivables |
180,342,925 | |||
Fixed Assets |
4,176,818 | |||
Intangible Assets |
12,451,763 | |||
Other Assets |
14,416,029 | |||
Total Assets |
$ | 260,444,694 | ||
Liabilities |
||||
Deposits |
$ | 174,406,310 | ||
Fed Funds |
11,988,123 | |||
Treasury Demand Notes |
0 | |||
Trading Liabilities |
385,470 | |||
Other Borrowed Money |
34,999,265 | |||
Acceptances |
0 | |||
Subordinated Notes and Debentures |
7,779,967 | |||
Other Liabilities |
6,530,991 | |||
Total Liabilities |
$ | 236,090,126 | ||
Equity |
||||
Minority Interest in
Subsidiaries |
$ | 1,647,451 | ||
Common
and Preferred Stock |
18,200 | |||
Surplus |
12,642,020 | |||
Undivided Profits |
10,046,897 | |||
Total Equity Capital |
$ | 24,354,568 | ||
Total Liabilities and Equity Capital |
$ | 260,444,694 |
To the best of the undersigneds determination, as of the date hereof, the above financial information is true and correct. |
U.S. Bank National Association | ||||
By: |
/s/ George J. Rayzis | |||
Vice President |
6